Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway

Published:2022-12 Issue: Volume:113 Page:109427
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Miao Yang,Li Xiaohe,Yang Yue,Zhang Jianwei,Chen Li,Zhang Qianyi,Li Wenqi,Liu Ying,Zhang Xianfeng,Gu Ruimin,Yang Cheng

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference52 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am. J. Respir. Crit. Care Med.,2011

2. Idiopathic Pulmonary Fibrosis;Lederer;N. Engl. J. Med.,2018

3. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis;Bjoraker;Am. J. Respir. Crit. Care Med.,1998

4. Clinical significance of histological classification of idiopathic interstitial pneumonia;Flaherty;Eur. Respir. J.,2002

5. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis;Nicholson;Am. J. Respir. Crit. Care Med.,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress;MedComm – Future Medicine;2024-07-19

2. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

3. Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway;Frontiers in Pharmacology;2023-09-15

4. Insights on the mechanism of bleomycin to induce lung injury and associated in vivo models: A review;International Immunopharmacology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3